Clinical Trial Update: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating the safety and efficacy of psilocybin in participants with treatment-resistant depression; the trial is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: Treatment Resistant Depression | Phase 2 | Status: ACTIVE_NOT_RECRUITING